Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Encryption: A Key Guardian of Our Digital Future

By Chuck Brooks and Bill Bowers.


Every time you send a text, pay for groceries with your phone, or use your health site, you are relying on encryption. It’s an invisible shield that protects your data from prying eyes. Encryption is more than just a technological protection; it is the basis for digital trust.

Encryption is more than just safeguarding data; it is also about protecting people. It helps ensure privacy by protecting persons from spying and exploitation. And it is widely adopted to help ensure digital transaction security. For National Security it serves to protect key infrastructure and government communications. And it has a human rights function by providing citizens with peace of mind by ensuring the safety of their personal information. In places where surveillance is widespread, encryption can even defend free expression and opposition. It is a human right in this digital age.

In my book Inside Cyber: How AI, 5G, IoT, and Quantum Computing Will Transform Privacy and Security, I referred to encryption as the “linchpin of privacy and commerce in a connected society.” Without it, the digital economy would crumble under the strain of criminality, fraud, and spying.

IgA Nephropathy in Adults

IgA nephropathy involves deposition of IgA-containing immune complexes in the glomerular mesangium, triggering glomerular inflammation and scarring.

IgA nephropathy is the most common cause of immune-mediated glomerular disease worldwide, with an estimated global incidence between 1.4 and 2.5 per 100 000 persons in the US.

Up to 50% of patients with IgA nephropathy develop kidney failure within 10 years of diagnosis, and life expectancy is estimated to be 6 years shorter for those with IgA nephropathy compared with matched controls.

📄 This Review summarizes the pathophysiology, epidemiology, clinical presentation, diagnosis, treatment, and prognosis of primary IgA nephropathy in adults.


This review discusses the pathophysiology, epidemiology, clinical presentation, diagnosis, treatment, and prognosis of primary IgA nephropathy (IgAN) in adults, with a focus on treatment recommendations based on the 2025 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for IgAN.

Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”

A new study in Communications Biology provides evidence that a psychedelic drug induces a hybrid sleep-wake state in active mice. This unusual brain activity suggests a potential mechanism for how psychedelics might help remodel neural connections.

Why I Quit ChatGPT and Switched to Claude

“AI will most likely lead to the end of the world, but in the meantime there will be great companies created.” — Sam Altman, OpenAI CEO

I used to think that was dark humor.

This week, I stopped laughing — and cancelled my ChatGPT subscription.

Not because of the technology. Because of the values.

On February 27, Anthropic refused to give the Pentagon unrestricted access to its AI for mass surveillance and autonomous killer weapons. Within hours, OpenAI’s Sam Altman swooped in and took the deal.

One company held the line. The other sprinted to cross it.

Australian consortium to develop quantum biotechnology platform to transform Alzheimer’s treatment discovery

“Our system provides a pathway towards a fast, scalable tool for measuring real-time brain activity in synthetic tissue cultures that replicate human brain tissue,” Associate Professor Simpson said.

If successful, this brain-on-chip technology could help evaluate the effectiveness of treatments for neurological diseases, including Alzheimer’s, schizophrenia, epilepsy and anxiety, in the laboratory before moving into expensive and complex human trials.

/* */